UroAlert - Oncology Weekly

Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Chemotherapy-naïve and CYP17 Inhibitor-naïve Patients: Follow-up from the ARADES and ARAFOR Trials.

Survival Outcomes in Octogenarian and Nonagenarian Patients Treated with First-line Androgen Deprivation Therapy for Organ-confined Prostate Cancer.

Peri-prostatic Fat Volume Measurement as a Predictive Tool for Castration Resistance in Advanced Prostate Cancer.

Prognostic Biomarkers Used for Localised Prostate Cancer Management: A Systematic Review.

Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine.

Dosimetric impact of intrafraction changes in MR-guided high-dose-rate (HDR) brachytherapy for prostate cancer.

The psychological impact of prostate biopsy: prevalence and predictors of procedure-related distress.

Drug-Eluting Biopsy Needle as a Novel Strategy for Antimicrobial Prophylaxis in Transrectal Prostate Biopsy.

Technical note: TROG 15.01 SPARK trial multi-institutional imaging dose measurement.

Prevalence and survival prognosis of prostate cancer in patients with end-stage renal disease: a retrospective study based on the Korea national database (2003-2010).

Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer.

Vinculin and filamin-C are two potential prognostic biomarkers and therapeutic targets for prostate cancer cell migration.

Pathological Concordance between Prostate Biopsies and Radical Prostatectomy Using Transperineal Sector Mapping Biopsies: Validation and Comparison with Transrectal Biopsies.

Androgen Deprivation Therapy and the Risk of Anemia in Men with Prostate Cancer.

Robot-assisted surgery in a broader healthcare perspective: a difference-in-difference-based cost analysis of a national prostatectomy cohort.

Identifying intermediate-risk candidates for active surveillance of prostate cancer.

PSMA-targeted (18)F-DCFPyL PET/CT in the Preoperative Staging of Men with High-risk Prostate Cancer: Results of a Prospective Phase II Single-Center Study.

Clinical Outcomes of Chemotherapy-Naïve Men with Metastatic Castration-Resistant Prostate Cancer and Low Baseline PSA Treated with Enzalutamide vs Placebo.

Characterization of efficacy and toxicity after high-dose pelvic reirradiation with palliative intent for genitourinary second malignant neoplasms or local recurrences after full-dose radiation therapy in the pelvis: A high-volume cancer center experience

Can the Day 0 CT-scan predict the post-implant scanning? Results from 136 prostate cancer patients.

Impact of abiraterone on patient-related outcomes in metastatic castration-resistant prostate cancer: current perspectives.

Timing of PSA Nadir after Radical Prostatectomy and Risk of Biochemical Recurrence.

A global, incremental development method for a web-based prostate cancer treatment decision aid and usability testing in a Dutch clinical setting.

Safety and Feasibility of Direct MRI-Guided Transperineal Prostate Biopsy Using a Novel MRI-Safe Robotic Device.

Prostate cancer: in-bore magnetic resonance guided biopsies at active surveillance inclusion improve selection of patients for active treatment.

Radiation therapy for oligorecurrence in prostate cancer. Preliminary results of our centre.

Patient-reported intestinal toxicity from whole pelvis intensity-modulated radiotherapy: First quantification of bowel dose-volume effects.

Evaluation of MR imaging-targeted biopsies of the prostate in biopsy-naïve patients. A single centre study.

Long-term Oncologic Outcomes of Robotic-assisted Radical Prostatectomy by a Single Surgeon.

(68)Ga-PSMA PET/CT impact on prostate cancer management.

Recent advances in circulating tumor cells and cell-free DNA in metastatic prostate cancer: a review.

Vertebral Myeloma Mimicking Prostatic Carcinoma Metastasis in 68Ga-PSMA PET/CT.

Sociodemographic disparities in the utilization of proton therapy for prostate cancer at an urban academic center.

Adverse effects of androgen deprivation therapy in patients with prostate cancer: focus on metabolic complications.

Current trends in patient enrollment for robotic-assisted laparoscopic prostatectomy in Belgium.

Change in PSA concentration in men with PSA

PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer.

Robotic Surgical System for Radical Prostatectomy: A Health Technology Assessment.

A subset of high Gleason grade prostate carcinomas contain a large burden of prostate cancer syndecan-1 positive stromal cells.

A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer: Authors.

Patients' Perspective on Participation in Care With or Without the Support of a Smartphone App During Radiotherapy for Prostate Cancer: Qualitative Study.

Role of MRI in the Use of an Absorbable Hydrogel Spacer in Men Undergoing Radiation Therapy for Prostate Cancer: What the Radiologist Needs to Know.

UroAlert - Oncology Weekly

Bladder Cancer

Renal Cancer

Prostate Cancer

Upper Tract Tumors

UroAlert - Oncology Weekly

Bladder Cancer

Renal Cancer

Prostate Cancer

Upper Tract Tumors

Login